FinanceUnited Kingdom Official institution
Advanz Pharma recalls selected Mynzepli 40 mg/mL syringe batches as a precaution
Advanz Pharma Limited is recalling specified batches of Mynzepli 40 mg/mL injectable solution sold in pre-filled syringes. The company frames the action as precautionary. It is filed as a Class 2 medicines recall under reference EL(26)A/44.
This summary was generated by AI; the official source prevails.
What does it mean?
Advanz Pharma is asking for certain batches of Mynzepli pre-filled syringes to be recalled. The company says this is a precaution, and the notice gives the strength as 40 mg/mL.
Who is affected?
People using Mynzepli 40 mg/mL pre-filled syringes from the batches named in the recall notice, and the pharmacies and wholesalers that supply them.